These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 17719120)

  • 1. In situ-forming hydrogels for sustained ophthalmic drug delivery.
    Nanjawade BK; Manvi FV; Manjappa AS
    J Control Release; 2007 Sep; 122(2):119-34. PubMed ID: 17719120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In situ gelling polymers in ocular drug delivery systems: a review.
    Mundada AS; Avari JG
    Crit Rev Ther Drug Carrier Syst; 2009; 26(1):85-118. PubMed ID: 19496748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design and evaluation of thermoreversible in situ gelling system of forskolin for the treatment of glaucoma.
    Gupta S; Samanta MK
    Pharm Dev Technol; 2010; 15(4):386-93. PubMed ID: 19772380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in ocular drug delivery.
    Achouri D; Alhanout K; Piccerelle P; Andrieu V
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1599-617. PubMed ID: 23153114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoparticles laden in situ gelling system for ocular drug targeting.
    Kumar D; Jain N; Gulati N; Nagaich U
    J Adv Pharm Technol Res; 2013 Jan; 4(1):9-17. PubMed ID: 23662277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In situ gel-forming system: an attractive alternative for nasal drug delivery.
    Wang X; Liu G; Ma J; Guo S; Gao L; Jia Y; Li X; Zhang Q
    Crit Rev Ther Drug Carrier Syst; 2013; 30(5):411-34. PubMed ID: 24099327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solid lipid nanoparticles for ocular drug delivery.
    Seyfoddin A; Shaw J; Al-Kassas R
    Drug Deliv; 2010; 17(7):467-89. PubMed ID: 20491540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
    Dahan A; Hoffman A
    J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravesical drug delivery: Challenges, current status, opportunities and novel strategies.
    GuhaSarkar S; Banerjee R
    J Control Release; 2010 Dec; 148(2):147-59. PubMed ID: 20831887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymeric hydrogels for novel contact lens-based ophthalmic drug delivery systems: a review.
    Xinming L; Yingde C; Lloyd AW; Mikhalovsky SV; Sandeman SR; Howel CA; Liewen L
    Cont Lens Anterior Eye; 2008 Apr; 31(2):57-64. PubMed ID: 17962066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and Development of Thermoreversible Ophthalmic In Situ Hydrogel of Moxifloxacin HCl.
    Shastri DH; Prajapati ST; Patel LD
    Curr Drug Deliv; 2010 Jul; 7(3):238-43. PubMed ID: 20497100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Situ Gelling Ophthalmic Drug Delivery System: An Overview and Its Applications.
    Sheshala R; Kok YY; Ng JM; Thakur RR; Dua K
    Recent Pat Drug Deliv Formul; 2015; 9(3):237-48. PubMed ID: 26205681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Availability of polymeric nanoparticles for specific enhanced and targeted drug delivery.
    Kiriyama A; Iga K; Shibata N
    Ther Deliv; 2013 Oct; 4(10):1261-78. PubMed ID: 24116911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel micelle carriers for cyclosporin A topical ocular delivery: in vivo cornea penetration, ocular distribution and efficacy studies.
    Di Tommaso C; Bourges JL; Valamanesh F; Trubitsyn G; Torriglia A; Jeanny JC; Behar-Cohen F; Gurny R; Möller M
    Eur J Pharm Biopharm; 2012 Jun; 81(2):257-64. PubMed ID: 22445900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hydrogels for controlled pulmonary delivery.
    Du J; Du P; Smyth HD
    Ther Deliv; 2013 Oct; 4(10):1293-305. PubMed ID: 24116913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photoresponsive hydrogels for biomedical applications.
    Tomatsu I; Peng K; Kros A
    Adv Drug Deliv Rev; 2011 Nov; 63(14-15):1257-66. PubMed ID: 21745509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In situ-forming hydrogels--review of temperature-sensitive systems.
    Ruel-Gariépy E; Leroux JC
    Eur J Pharm Biopharm; 2004 Sep; 58(2):409-26. PubMed ID: 15296964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical drug delivery systems: a patent review.
    Singh Malik D; Mital N; Kaur G
    Expert Opin Ther Pat; 2016; 26(2):213-28. PubMed ID: 26651499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fabrication of a drug delivery system that enhances antifungal drug corneal penetration.
    Li J; Li Z; Liang Z; Han L; Feng H; He S; Zhang J
    Drug Deliv; 2018 Nov; 25(1):938-949. PubMed ID: 29658325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral pulsatile delivery systems based on swellable hydrophilic polymers.
    Gazzaniga A; Palugan L; Foppoli A; Sangalli ME
    Eur J Pharm Biopharm; 2008 Jan; 68(1):11-8. PubMed ID: 17888641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.